Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
329 DKK | -2.66% | +11.00% | +166.40% |
Apr. 17 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
Mar. 29 | Certain Shares of Gubra A/S are subject to a Lock-Up Agreement Ending on 29-MAR-2024. | CI |